World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
121
Citations
51471
World Ranking
3623
National Ranking
1999

Jerry R. Mendell publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jerry R. Mendell sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 623 publications — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Jerry R. Mendell D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jerry R. Mendell sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 121 D-Index — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2020 - Member of the National Academy of Medicine (NAM)

Overview

Jerry R. Mendell is affiliated with The Ohio State University in the United States. Their research encompasses medicine and biochemistry, genetics, and molecular biology, with a significant focus on neurogenetic and muscular disorders, RNA modifications and cancer, congenital anomalies and fetal surgery, CRISPR and genetic engineering, virus-based gene therapy, muscle physiology and disorders, and CAR-T cell therapy.

The scientist has a publication record in several frequent venues, including:

  • Neurology
  • Neuromuscular Disorders
  • Molecular Therapy - Methods & Clinical Development
  • Nature Medicine
  • Journal of Neuromuscular Diseases

Key frequent coauthors in their work include:

  • Sitra Tauscher-Wisniewski
  • Richard S. Finkel
  • Anne M. Connolly
  • Perry B. Shieh
  • M. Iammarino

Some of the notable recent papers featuring Jerry R. Mendell are:

  • Current Clinical Applications of In Vivo Gene Therapy with AAVs, 2020, Molecular Therapy
  • Five-Year Extension Results of the Phase 1 START Trial of Onasemnogene Abeparvovec in Spinal Muscular Atrophy, 2021, JAMA Neurology

Additional influential papers related to their field include works led by other authors but relevant to shared research areas:

  • Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial, 2021, The Lancet Neurology
  • Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial, 2022, Nature Medicine
  • Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the Phase III SPR1NT trial, 2022, Nature Medicine

Their main fields of study comprise:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Subfields that are the focus of their research include:

  • Genetics
  • Molecular Biology
  • Surgery
  • Oncology
  • Cardiology and Cardiovascular Medicine

The breadth of research topics addressed by Jerry R. Mendell covers:

  • Neurogenetic and Muscular Disorders Research
  • RNA modifications and cancer
  • Congenital Anomalies and Fetal Surgery
  • CRISPR and Genetic Engineering
  • Virus-based gene therapy research
  • Muscle Physiology and Disorders
  • CAR-T cell therapy research

Among their recognitions, Jerry R. Mendell was named a Member of the National Academy of Medicine (NAM) in 2020.

Best Publications

  • Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model

    Janaiah Kota;Raghu R. Chivukula;Kathryn A. O'Donnell;Erik A. Wentzel

  • Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy

    Jerry R. Mendell;Samiah Al-Zaidy;Richard Shell;W. Dave Arnold

  • Evidence-based path to newborn screening for Duchenne muscular dystrophy.

    Jerry R. Mendell;Chris Shilling;Nancy D. Leslie;Kevin M. Flanigan

  • Inclusion body myositis and myopathies.

    Robert C. Griggs;Valerie Askanas;Salvatore DiMauro;Andrew Engel

  • Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver

    Shu Hao Hsu;Bo Wang;Janaiah Kota;Jianhua Yu

  • Astrocytes from familial and sporadic ALS patients are toxic to motor neurons

    Amanda M Haidet-Phillips;Mark E Hester;Carlos J Miranda;Kathrin Meyer

  • Eteplirsen for the treatment of Duchenne muscular dystrophy

    Jerry R. Mendell;Louise R. Rodino‐Klapac;Zarife Sahenk;Kandice Roush

  • The Survival Motor Neuron Protein in Spinal Muscular Atrophy

    Daniel D. Coovert;Thanh T. Le;Patricia E. McAndrew;John Strasswimmer

  • Dystrophin Immunity in Duchenne's Muscular Dystrophy

    Jerry R. Mendell;Katherine Campbell;Katherine Campbell;Louise Rodino-Klapac;Louise Rodino-Klapac;Zarife Sahenk;Zarife Sahenk

  • Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria

    Richard J. Barohn;John T. Kissel;John R. Warmolts;Jerry R. Mendell

  • Clinical trial in duchenne dystrophy. I. The design of the protocol

    Michael H. Brooke;Robert C. Griggs;Jerry R. Mendell;Gerald M. Fenichel

  • Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy

    J.R. Mendell;R.T. Moxley;R.C. Griggs;M.H. Brooke

  • Myoblast Transfer in the Treatment of Duchenne's Muscular Dystrophy

    Jerry R. Mendell;John T. Kissel;Anthony A. Amato;Wendy King

  • Microvascular deposition of complement membrane attack complex in dermatomyositis.

    John T. Kissel;Jerry R. Mendell;Kottil W. Rammohan

  • Identification of Proximal Spinal Muscular Atrophy Carriers and Patients by Analysis of SMNT and SMNC Gene Copy Number

    P.E. McAndrew;D.W. Parsons;L.R. Simard;C. Rochette

  • A Phase I/II trial of MYO-029 in Adult Subjects with Muscular Dystrophy

    Kathryn R. Wagner;James L. Fleckenstein;Anthony A. Amato;Richard J. Barohn

  • Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy.

    Jerry R. Mendell;Nathalie Goemans;Linda P. Lowes;Lindsay N. Alfano

  • Current Clinical Applications of In Vivo Gene Therapy with AAVs.

    Jerry R. Mendell;Jerry R. Mendell;Samiah A. Al-Zaidy;Louise R. Rodino-Klapac;Kimberly Goodspeed

  • Clinical investigation in duchenne dystrophy: 2. Determination of the “power” of therapeutic trials based on the natural history

    Brooke Mh;Fenichel Gm;Griggs Rc;Mendell

  • Painful sensory neuropathy: prospective evaluation using skin biopsy.

    M.I. Periquet;V. Novak;M.P. Collins;H.N. Nagaraja

Frequent Co-Authors

Zarife Sahenk
Zarife Sahenk Nationwide Children's Hospital
John T. Kissel
John T. Kissel The Ohio State University
Brian K. Kaspar
Brian K. Kaspar Insmed Incorporated
Kevin M. Flanigan
Kevin M. Flanigan The Ohio State University
Thomas W. Prior
Thomas W. Prior The Ohio State University
Robert C. Griggs
Robert C. Griggs University of Rochester Medical Center
Arthur H.M. Burghes
Arthur H.M. Burghes The Ohio State University
Richard J. Barohn
Richard J. Barohn University of Missouri
Alan Pestronk
Alan Pestronk Washington University in St. Louis
Christopher M. Walker
Christopher M. Walker The Ohio State University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in broadening their career opportunities in healthcare, a variety of online degree programs offer flexible, affordable ways to advance your education. Many aspiring leaders consider an online master of health administration to prepare for management roles in hospitals, clinics, and healthcare organizations. This path combines business skills and healthcare knowledge to improve systems and patient outcomes.

If you’re working toward a terminal degree, the cheapest online mha options are available to help make higher education more accessible without the heavy financial burden. Additionally, nurses seeking advanced practice roles can benefit from the shortest post master's pmhnp online programs, which allow quick specialization in psychiatric mental health nursing.

For those who wish to reach the highest clinical ranks in nursing, the cheapest bsn to dnp programs provide a streamlined and cost-effective option to obtain a Doctor of Nursing Practice degree. Whether you’re aiming to lead healthcare systems or specialize in patient care, these accredited online pathways empower you to make a meaningful impact on the healthcare landscape.

Best Scientists Citing Jerry R. Mendell

Trending Scientists

Recently Published Articles